Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Siskind

Showing results (261-270 of 292) with videos related to

Pageof 30
Sort By:
Bjpsych Open|October 3, 2024
Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophreniaDan Siskind, Claudia Bull, Shuichi Suetani, et al.
Neuropsychiatric Disease and Treatment|July 1, 2025
A Novel Digital Intervention to Facilitate Diabetes Self-Management Among People with Schizophrenia and Related Disorders: Development and Acceptability Testing of SMARTUrska Arnautovska, Gabrielle Ritchie, Rebecca Soole, et al.
The Australian and New Zealand Journal of Psychiatry|March 22, 2021
Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigmDaniel Perkins, Jerome Sarris, Susan Rossell, et al.
Journal of Psychiatry & Neuroscience : JPN|April 17, 2020
Consensus statement on the use of clozapine during the COVID-19 pandemicDan Siskind, William G Honer, Scott Clark, et al.
Journal of Psychiatry & Neuroscience : JPN|April 4, 2020
Consensus statement on the use of clozapine during the COVID-19 pandemicDan Siskind, William G. Honer, Scott Clark, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 15, 2026
New approaches to clinical research for people with schizophreniaKatherine Beck, Matthew Broome, Saeed Farooq, et al.
Journal of Psychiatry & Neuroscience : JPN|June 26, 2020
Clozapine and COVID-19: The authors respondDan Siskind, William G Honer, Scott Clark, et al.
BMC Medical Research Methodology|November 19, 2025
Could master protocols be adapted for effectiveness-implementation hybrid studies?Justin J Chapman, Taren Massey-Swindle, Urska Arnautovska, et al.
The Australian and New Zealand Journal of Psychiatry|April 26, 2026
Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendationsNicola Warren, Cullen O'Gorman, Frances Dark, et al.
The Lancet Regional Health. Western Pacific|October 28, 2025
Psychotropic medication consumption before and after onset of COVID-19 pandemic in 91 countries and regions: a time-series analysisCaige Huang, Yu Yang, Yue Wei, et al.
Pageof 30

Showing results (261-270 of 292) with videos related to

Sort By:
Pageof 30
Bjpsych Open|October 3, 2024
Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophreniaDan Siskind, Claudia Bull, Shuichi Suetani, et al.
Neuropsychiatric Disease and Treatment|July 1, 2025
A Novel Digital Intervention to Facilitate Diabetes Self-Management Among People with Schizophrenia and Related Disorders: Development and Acceptability Testing of SMARTUrska Arnautovska, Gabrielle Ritchie, Rebecca Soole, et al.
The Australian and New Zealand Journal of Psychiatry|March 22, 2021
Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigmDaniel Perkins, Jerome Sarris, Susan Rossell, et al.
Journal of Psychiatry & Neuroscience : JPN|April 17, 2020
Consensus statement on the use of clozapine during the COVID-19 pandemicDan Siskind, William G Honer, Scott Clark, et al.
Journal of Psychiatry & Neuroscience : JPN|April 4, 2020
Consensus statement on the use of clozapine during the COVID-19 pandemicDan Siskind, William G. Honer, Scott Clark, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 15, 2026
New approaches to clinical research for people with schizophreniaKatherine Beck, Matthew Broome, Saeed Farooq, et al.
Journal of Psychiatry & Neuroscience : JPN|June 26, 2020
Clozapine and COVID-19: The authors respondDan Siskind, William G Honer, Scott Clark, et al.
BMC Medical Research Methodology|November 19, 2025
Could master protocols be adapted for effectiveness-implementation hybrid studies?Justin J Chapman, Taren Massey-Swindle, Urska Arnautovska, et al.
The Australian and New Zealand Journal of Psychiatry|April 26, 2026
Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendationsNicola Warren, Cullen O'Gorman, Frances Dark, et al.
The Lancet Regional Health. Western Pacific|October 28, 2025
Psychotropic medication consumption before and after onset of COVID-19 pandemic in 91 countries and regions: a time-series analysisCaige Huang, Yu Yang, Yue Wei, et al.
Pageof 30